This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Vallon Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of VLON?
Owner Type	Number of Shares	Ownership Percentage
Hedge Funds	740,000	5.49%
VC/PE Firms	740,000	5.49%
Public Companies	843,750	6.26%
Institutions	1,058,262	7.85%
Individual Insiders	1,061,661	7.87%
Private Companies	1,523,797	11.3%
General Public	7,514,872	55.7%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 97.9%.

Top Shareholders

Top 25 shareholders own 44.26% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
11.3%	Medice Arzneimittel PÜTter Gmbh & Co. Kg	1,523,797	US$609.5k	0%	no data
6.26%	Arcturus Therapeutics Holdings Inc.	843,750	US$337.5k	0%	no data
5.49%	Armistice Capital, LLC	740,000	US$296.0k	0%	0.01%
5.49%	Fgp Protective Opportunity Master Fund	740,000	US$296.0k	0%	92.19%
5.49%	Lincoln Park Capital, LLC	740,000	US$296.0k	0%	4.9%
3.78%	Dov Malnik	509,781	US$203.9k	0%	no data
3.78%	Tomer Feingold	509,781	US$203.9k	0%	no data
0.79%	Virtu Financial LLC, Asset Management Arm	106,120	US$42.4k	-18.5%	0.01%
0.47%	Two Sigma Investments, LP	62,836	US$25.1k	0%	no data
0.27%	Two Sigma Securities, LLC, Asset Management Arm	36,604	US$14.6k	0%	no data
0.16%	Geode Capital Management, LLC	21,569	US$8.6k	0%	no data
0.15%	UBS Asset Management AG	20,347	US$8.1k	0%	no data
0.14%	State Street Global Advisors, Inc.	18,921	US$7.6k	0%	no data
0.13%	Joseph Payne	17,500	US$7.0k	0%	no data
0.088%	Tower Research Capital LLC	11,907	US$4.8k	-0.95%	no data
0.087%	Cetera Financial Holdings, Inc., Asset Management Arm	11,711	US$4.7k	0%	no data
0.077%	Wilcoxson Wealth Management	10,350	US$4.1k	0%	no data
0.076%	Millennium Management LLC	10,274	US$4.1k	0%	no data
0.071%	Marella Thorell	9,506	US$3.8k	0%	no data
0.066%	David Baker	8,843	US$3.5k	0%	no data
0.056%	The Lind Partners, LLC	7,500	US$3.0k	-99%	0.01%
0.046%	Leanne Kelly	6,250	US$2.5k	0%	no data
0.00074%	Archer Investment Corporation	100	US$39.9	0%	no data
0.00067%	Morgan Stanley, Investment Banking and Brokerage Investments	90	US$36.1	0%	no data
0.00042%	Wells Fargo & Company, Private Banking and Investment Banking Arm	57	US$22.7	39%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2023/04/23 09:54
End of Day Share Price	2023/04/21 00:00
Earnings	2022/12/31
Annual Earnings	2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Vallon Pharmaceuticals, Inc. is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Raghuram Selvaraju	H.C. Wainwright & Co.